Reustle A.; Di Marco M.; Meyerhoff C.; Nelde A.; Walz J.S.; Winter S.; Kandabarau, S.; Büttner, F.; Haag, M.; Backert, L.; Kowalewski, D.; Rausch, S.; Hennenlotter, J.; Stühler, V.; Scharpf, M.; Fend, F.; Stenzl, A.; Rammensee, H.G.; Bedke, J.; Stevanović, S.; Schwab, M.; Schaeffeler, E. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Genome Med 2020, 12(394). doi:10.1186/s13073-020-00731-8
Reustle, A.; Fisel, P.; Renner, O.; Büttner, F.; Winter, S.; Rausch, S.; Kruck, S.; Nies, A.T.; Hennenlotter, J.; Scharpf, M.; Fend, F.; Stenzl, A.; Bedke, J.; Schwab, M.; Schaeffeler, E. Characterization of the Breast Cancer Resistance Protein (BCRP/ABCG2) in clear cell renal cell carcinoma. Int J Cancer 2018 143(12), 3181-3193, doi: 10.1002/ijc.31741.
Schaeffeler, E.; Büttner, F.; Reustle, A.; Klumpp, V.; Winter, S.; Rausch, S.; Fisel, P.; Hennenlotter, J.; Kruck, S.; Stenzl, A.; Warheit, J.; Sonntag, D.; Scharpf, M.; Fend, F.; Agaimy, A.; Hartmann, A.; Bedke, J.; Schwab, M. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin. Eur Urol Focus 2019, 5, 608–18. doi:10.1016/j.euf.2018.01.016
Büttner, F.; Winter, S.; Rausch, S.; Reustle, A.; Kruck, S.; Junker, K.; Stenzl, A.; Agaimy, A.; Hartmann, A.; Bedke, J.; Schwab, M.; Schaeffeler, E. Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron. Eur Urol 2015, 68(6), 1016–1020, doi: 10.1016/j.eururo.2015.05.045
Curriculum Vitae
Education and Professional Career
Since 2018
Scientist at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Since 2018
Training as Clinical Chemist at the Robert-Bosch-Hospital
2014-2018
PhD Thesis at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (Prof. Dr. M. Schwab); „Elucidation of underlying genomic, epigenomic and metabolomic factors contributing to the expression of candidate targets identified by HLA ligandome analysis in clear cell renal cell carcinoma“
2013-2014
Master thesis at the Department of Infectiology, Molecular Virology, University Hospital Heidelberg
2011
Bachelor thesis at the Department of Infectiology, Molecular Virology, University Hospital Heidelberg
2008-2014
Studies of Molecular Biotechnology at the Ruprecht-Karls University Heidelberg, Heidelberg, Germany
